Domperidone for Gastroparesis in Solid Organ Transplantation
Domperidone for Gastroparesis Associated With Solid Organ Transplantation
Sponsor: David J. Lederer, M.D.
Terminated
Lack of perceived need for domperidone in this population
Other Gastroesophageal Reflux trials with similar outcome
Listed as NCT00552422, this NA trial focuses on Gastroesophageal Reflux and Gastroparesis and remains terminated or withdrawn. Sponsored by David J. Lederer, M.D., it has been updated 8 times since 2007, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2023 — Jul 2024 [monthly]
Terminated NA
-
Dec 2022 — Jan 2023 [monthly]
Terminated NA
-
Jan 2021 — Dec 2022 [monthly]
Terminated NA
▶ Show 3 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Terminated NA
-
Feb 2017 — Jun 2018 [monthly]
Terminated NA
-
Jan 2017 — Feb 2017 [monthly]
Terminated NA
First recorded
Mar 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- David J. Lederer, M.D.
For direct contact, visit the study record on ClinicalTrials.gov .